Nephroapp
Exam Cases MCQ Bank

Search

Find tools, topics, and resources

Welcome to Nephroapp
Sign in to keep your progress and bookmarks.
Log in Create account
Explore
Exam cases MCQ Bank Topics Plans and pricing
App
Explore NephroApp
Exam Cases MCQ Bank

Study

Exam cases
MCQ Bank
Fast Recaps
Plans and pricing
‹ Exam Cases
PD Peritonitis (ISPD)
Case map
Fast Recap Case scenarios Viva Q&A Spoken approach Escalation ladder Management Quick reference Red flags Flowchart Exam traps & pitfalls Differential Examiner keywords Investigations & data Recent changes Immediate priorities Why it happens
Exam tools
Study
📋Topics 🎯By branch
🎯 NephroApp · Exam Cases
PD Peritonitis (ISPD)
nephroapp.com
🔥 #1 most asked · 43 sittings · 72× Peritoneal Dialysis SCFHS Consultant Viva ISPD 2022

PD Peritonitis (ISPD)

By Dr. Hossam Abohassan · Updated Nov 13, 2026

PD peritonitis is the single most-asked PD case in the viva (the examiner drills diagnosis, exact empiric intraperitoneal antibiotics, duration by organism, and the indications for catheter removal). The examiner waits for three keywords: cloudy effluent, effluent WBC >100 with >50% neutrophils, and intraperitoneal vancomycin + ceftazidime. He will then escalate: fungal? refractory? when do you pull the catheter? Anchor every answer on ISPD 2022.

Practise 23 MCQs on this topicExam-style questions with explanations →

Watch & listen to this topic

🎬 Full video · the whole approach, animated

Open on YouTube ↗

⚡ NephroApp short · 2 min summary

Your browser does not support audio playback.

🎧 Full podcast

Your browser does not support audio playback.

⚡ NephroApp short · 2 min summary

Your browser does not support audio playback.

🎧 Full podcast

Your browser does not support audio playback.
Exam links & past questions
📌 Exam topic #1 · PD peritonitis (ISPD) 43 sittings · 72×
Also on this exam topic: DrillPD infections: peritonitis and exit-site overview TopicPD peritonitis: dry abdomen, empiric IP cover and catheter removal TopicPD peritonitis: empiric IP antibiotics, relapse work-up and catheter removal TopicPD indications, contraindications and peritonitis overview TopicEPS after recurrent peritonitis: stop PD, CT, tamoxifen, steroids and enterolysis
🧩 Don't skip the general measures: PD patient — protect the door
🪜 Treatment ladder: PD peritonitis
⚖️ Comparison tables: Relapsing vs recurrent vs repeat vs refractory peritonitis Causes of cloudy / abnormal PD effluent PD peritonitis: duration and catheter by organism
🎯 Asked in the real exam · 56 reports — answer each aloud
  1. PD peritonitis: diagnostic criteria and empirical therapy; culture-negative, improving at day 3 with effluent WBC under 100 — stop both, continue both, or stop the Gram-negative agent? Duration?Oct 2026
  2. PD peritonitis: diagnostic criteria and treatment.Oct 2026
  3. PD peritonitis: treatment and indications for PD catheter removal.Oct 2026
  4. Cloudy effluent in PD: differential diagnosis, diagnostic criteria of peritonitis, antibiotics, antifungal, vancomycin dosing/indication, drain/dwell/instill volumes and repeat cultureMar 2026
  5. PD exit-site/dressing with discharge fluid + inflammatory mass: differential (calciphylaxis, cancer, granuloma, exit-site/tunnel infection, peritonitis); investigations (what else x3); biopsy and treat calciphylaxis/peritonitis, antiemetics, ultrasoundMar 2026
  6. Last Thursday Session 2: 100kg ICU patient creat 600, K 6.5, severe acidosis, anuria >6h - CRRT (more convection than diffusion), filter clotted after 6h; peritonitis again; female ER weakness, Na 124 on VBG, euvolemic - diagnosis/urinary findings/treatment; FSGS management; young patient with HTN (radiology/cortisol/TSH/renin-aldosterone normal, K 5, bicarb 18) - diagnosis & management; kidney transplant ABMR on biopsy - treatment step by step (plasmapheresis said no, steroids dose, eculizumab/bortezomib = refer to tertiary).Jan 2026
  7. PD patient on daily hyperosmotic dextrose dwell, after 3 months presents with abdominal pain and weight loss, no signs of peritonitis - is this EPS?Nov 2025
  8. Q4: PD patient abdominal pain - peritonitis diagnosis/criteria/tttSep 2025
  9. Full exam recall - Committee 1 (5 cases) and Committee 2 (6 cases)Sep 2025
  10. Last Thursday's exam: pregnancy in post-transplant; PD peritonitis diagnosis & treatment; UF failure scenario; calciphylaxis scenario; prolonged bleeding AVF; endocarditis patient developing AKI after 1 week (-> PSGN); DM/HTN CKD G3 A2 management; causes of EPO resistance; SIADH criteria; pregnancy in advanced renal failure with diabetic nephropathy needing HD (dialysis prescription); diabetic creat rising 100->200 with NSAID use (NSAID-induced AKI); 23yo hematuria/proteinuria creat 104, 24h protein 1.6g, FSGS - treatment then ESRD - transplant advice; most common cause of abdominal pain in PD patient; renal biopsy precautions to reduce bleeding; ICU hypernatremia and treatment.May 2025
  11. Compiled Qs last Thursday: IgA nephropathy pathology and poor prognostic features; MN treatment; recurrent stones reaching RTA type 1 and treatment; hypokalemia with metabolic alkalosis in young patient (= Liddle); AMR and acute cellular rejection treatment; UF failure in PD; friable erythematous area near peritoneal exit (not peritonitis); evidence-based approaches to decrease CKD progression; hepatorenal syndrome treatment; secondary HTN reaching renal artery stenosis.May 2025
  12. PD questions: DDx of abdominal pain in PD; PET test; UF failure; peritonitis; friable tissue around exit site.May 2025
  13. Friable area bleeding on touch near exit site, no peritonitis, no exit/tunnel infection: approach.May 2025
  14. Peritonitis: diagnosis and treatment, and duration of antibiotics for each organism.May 2025
  15. PD patient 6 months with abdominal pain and fever: approach, diagnose peritonitis, treatment.Apr 2025
  16. Two stations of recalled cases. Station I: (1) management of focal FSGS (controversial), new drugs; (2) 30y male BP 190/120 c/o headache for 4 months — approach; (3) hyponatremia c/p types & Rx; (4) hypernatremia; (5) 30y male all of sudden Cr 3mg, acute or RPGN — types, causes, presentation, Rx. Station II: (1) CRRT dose, how to calculate, types; (2) PD peritonitis c/p & management, which cephalosporin and how much you give; (3) euvolemic hyponatremia; (4) autosomal dominant ADPKD, age, bleeds, approach → novel drugs, trials, tolvaptan (doses). Hyperkalemia, HTN, metabolic acidosis — which syndrome.Apr 2025
  17. Patient on CAPD with PD peritonitis — diagnosis and management of PD peritonitis, plus indications for PD catheter removal (ISPD 2022 guideline).Apr 2025
  18. Handwritten exam topic list (continued): peritonitis Dx/Mgt/organism; rising SCr; rising SCr plus blood urea DDx; myeloma cast and AKI in myeloma.Apr 2025
  19. Compiled exam topic list across stations and languages: AKI (causes, mechanism, CRRT/SLED, rhabdo, myeloma, sepsis); PD peritonitis Dx/Tx; hyponatremia/SIADH and causes in CKD/cirrhosis; secondary HTN algorithm; MN; lupus pulse steroid; HRS; hyperkalemia algorithm; Bartter/Gitelman/Alport; transplant rejection/donor; HD/PD/UF; renal biopsy precautions; pre-eclampsia; recurrent GN in pregnancy; hypocalcemia/cinacalcet; pedal edema.Apr 2025
  20. Session 2: ICU septic shock creat 500, K 7, MAP 65 (approach); commercial transplant to ER creat 400 3 days post-transplant; recurrent stones bicarb 14, K 3.2, RTA type 1 (mechanism and treatment); 28yo HTN with hyperkalemia (Gordon-type); peritonitis (diagnosis & detailed treatment, indications for PD catheter removal); CRS type 1 (approach, medical vs UF study).Apr 2025
  21. Exam set: 33F creat 2.3, BP 145/90, hematuria 2+, proteinuria 2+ (approach & DD); 13M hypokalemia (DD & Bartter management); 70M pneumonia/sepsis/AKI BP 70/40 (CRRT prescription); PD/APKD 6 weeks reduced effluent, catheter OK, clear, no peritonitis (cause? leak/loculated); mild chronic hyponatremia management; elderly female DM 1yr proteinuria, not HTN, normal retina (DD, work up as non-diabetic).Apr 2025
  22. PD peritonitis management: drain fluid, dwell 2 hours, take sample/culture, empirical intraperitoneal antibiotics (vancomycin + gentamicin or ceftazidime); choice depends on residual renal functionFeb 2025
  23. Committee 1 topics: approach to hyponatremia; solitary unilateral renal mass; AVF malfunction with thrill; workup of stone; nephrotic syndrome in 16yo (treatment of edema); PD outflow/inflow problem with abdominal pain, no peritonitis; ESRD on HD with anemia & hyperparathyroidism (treatment of anemia, doses, no correction, next step); secondary HTN; HTN patient develops proteinuria.Feb 2025
  24. First session 1: CRRT 100kg patient, reduce clotting risk (high FF); ABMR; peritonitis; lupus nephritis class IV management + cyclophosphamide side effects/prevention (hemorrhagic cystitis); 44y male recurrent renal stone (was RTA type 1); asymptomatic hyponatremia (was SIADH).Jan 2025
  25. PD peritonitis management per guidelines: how to give antibiotics, route, dwell time, who administers, and what to add besides antibiotics after sending cultureDec 2024
  26. Committee 1 (long): IDH; abdominal wall friable skin lesion bleeding easily near exit site, no exit-site/tunnel infection or peritonitis - cause & treatment; EPS risk factors & treatment; indication of dialysis in hepatorenal syndrome, modality, prescription (wanted discussion with patient/family that dialysis won't change outcome); CRRT dose & complications + study name and patient number; cause of glomerular hematuria + assessing renal function loss from biopsy in IgA; C3-mediated MPGN causes/diagnosis/treatment; immediate & late complications in kidney donor candidate; treatment of ACR by Banff score; hyponatremia new safe SIADH drugs; treatment of tertiary hyperparathyroidism + surgery complications; CKD progression prevention per guidelines; AKI risk factors in cardiovascular surgery in diabetic with heart failure.Sep 2024
  27. 45 y/o female PD patient with abdominal pain for ~5 years/episode: differential (is it peritonitis?) and approach to catheter malfunction/outflow obstruction.Jul 2024
  28. S1Q4: PD peritonitis definition; empiric antibiotics; treat at home or hospital. Q5: investigation of lithiasis (blood and urine).May 2024
  29. S1Q3: Increasing number of PD patients with peritonitis in your unit — why, problems, prevention.May 2024
  30. S2Q6: ESRD HTN on non-dihydropyridine CCB, on PD, cloudy fluid, peritonitis workup normal — what to do, what to suspect.May 2024
  31. PD pt (APKD), on PD 6 weeks, reduced effluent, catheter OK, effluent clear, no peritonitis, all else OK — cause? (leak vs loculated fluid).Feb 2024
  32. Examiner 1 (classic 'solid medicine' school) rapid-fire one question per branch: PD - peritonitis, exit-site, catheter migration, malfunction, infection (buzzwords expected).Feb 2024
  33. 25 y/o woman on peritoneal dialysis with hemorrhagic (bloody) effluent / hemoperitoneum: approach.Jan 2024
  34. Peritonitis diagnosis and treatment; duration of antibiotics for each organism.Sep 2023
  35. Handwritten study checklist of recalled consultant exam topics, organized by examiner/candidate ('Abou' section, top-left column): peritonitis Dx/Mgt/organism; resistant/secondary HTN initial workup; CRRT prescription; BK virus Dx/Bx/Mgt; hypoNa investigation/Mgt; MN (membranous nephropathy) risk/prognosis/Dx of SHU.
  36. Study checklist ('Abou' section, top-right column under 'Mgt'): AKI rhabdomyolysis (hyperK, chronic, hyperK) Mgt; HD with 15 yrs of dialysis - beta-2 microglobulin / dialysis (amyloidosis); PD recurrent peritonitis -> EPS (encapsulating peritoneal sclerosis) Mgt; BK virus; secondary HTN algorithm; lupus proteinuria.
  37. Study checklist ('Angad' section, left column): AKI causes & mechanism / CKD pre-renal & post-renal causes; dialysis modalities CRRT vs SLED; PD peritonitis Tx; HypoNa causes & how to determine the cause; Wegener Tx.
  38. Study checklist (bottom section, right column): HD pain (filter reaction - DWO); later Tx complications; PD peritonitis Dx + Mgt; DN (diabetic nephropathy) creat 3, antidiabetic drug Mgt; renal transplant cover load, Mgt, Dx, monitor; HUS investigation.
  39. PD peritonitis: diagnosis, treatment (antibiotics, antifungal?), heparin.
  40. Peritonitis: PD (indication CGdg management, indication of catheter removal).
  41. Criteria of peritonitis.
  42. How to diagnose PD (peritonitis)? Management (antifungal +++, heparin +++).
  43. Peritonitis: drug dosage and route of administration; indications for PD catheter removal
  44. Peritonitis: diagnosis and treatment
  45. Peritonitis scenario: diagnosis and management
  46. Indications and contraindications of peritoneal dialysis; treatment of peritonitis
  47. PD peritoneal infection (per ISPD recommendations)
  48. Peritonitis: diagnosis, management, organisms, indications for catheter removal
  49. Recurrent peritonitis (EPS?): diagnosis and treatment
  50. 56yo on APD 1 year with cloudy effluent: approach, diagnosis, diagnostic criteria, treatment
  51. Peritonitis and indications for PD catheter removal; how to treat peritonitis; ask about antibiotic therapy
  52. Encapsulating peritonitis (encapsulating peritoneal sclerosis): management
  53. PD patient presents with abdominal pain + fever + cloudy effluent dialysate: definition of peritonitis (ISPD); management; indications for catheter removal
  54. Woman 37 years, ESRD on PD, no fever, no abdominal pain, hemorrhagic effluent: causes (gyne/surgical... Pertraite); peritonitis definition/management (ISPD 2022); encapsulating peritonitis definition/management
  55. PD peritonitis: diagnosis criteria (leucocytosis >100); treatment Gram(+)/Gram(-) (don't forget 3rd generation cephalosporin in Gram(+) protocol). Intradialytic hypotension: causes; management (midodrine +++)
  56. PD peritonitis: diagnosis and treatment.
📌 Exam topic #83 · PD catheter removal — indications 1×
Also on this exam topic: DrillWhen do you remove a PD catheter? Indications, and when can you replace it (simultaneous vs delayed)?
🪜 Treatment ladder: PD peritonitis
🎯 Asked in the real exam · 1 report — answer each aloud
  1. Indications of peritoneal catheter removal.May 2025
Fast Recap · 7 stops

PD peritonitis at a glance

Sample before antibiotics, treat IP, know when the catheter comes out.

  1. Cloudy effluent Peritonitis until proven otherwise.
  2. 1 IP 2 Sampling, then IP therapy Culture bottles first, then IP vancomycin + ceftazidime.
  3. Catheter removal Fungal: now. Refractory: day 5.
1 Diagnosis 2 Sampling 3 Empirical therapy 4 Duration 5 Catheter removal 6 Relapse 7 Contamination
  1. 1

    Stop 1 · Diagnosis

    Diagnostic criteria

    Any 2 of 3; culture may still be pending.

    >100 WBC/µL ?
    1

    Clinical

    Abdominal pain and/or cloudy effluent.

    2

    Effluent cell count

    WBC >100/µL, >50% neutrophils, dwell ≥2 h.

    3

    Effluent culture

    Positive.

    Dry abdomen

    Instill ~1 L, dwell 2 h, drain and sample.

    Rapid-cycle APD

    >50% neutrophils strongly suggests peritonitis, even if WBC <100/µL.

    Memory hook

    “Cloud, Count, Culture: any two.”

    Exam trap

    Eosinophils: chemical peritonitis (icodextrin, solution or tubing).
    Red cells: haemoperitoneum (menstruation, ovulation).
    Pain alone: constipation, catheter malposition.

  2. 2

    Stop 2 · Investigations

    Diagnostic sampling

    Count, differential, Gram stain, culture before antibiotics; then treat at once.

    AER ANA 5–10 mL 3000 g 15 min
    Bedside

    Blood-culture bottles

    5–10 mL into aerobic and anaerobic.
    Lab within 6 h; delayed: 37 °C. Never refrigerate or freeze.

    Higher yield

    Centrifugation

    50 mL, 3000 g, 15 min; pellet in 3–5 mL supernatant.
    Yield rises 5–10 fold.

    Blood cultures if septic or immunosuppressed; swab exit-site discharge.

    Unit target

    Culture-negative <15% of episodes (specialised centres <10%); above it, review technique.

  3. 3

    Stop 3 · Treatment

    Empirical antibiotic therapy

    Gram-positive and Gram-negative cover, IP; unit antibiogram decides.

    IP V C ≥6 h dwell
    Gram-positive IP vancomycin
    CAPD 15–30 mg/kg every 5–7 days
    APD 15 mg/kg every 4 days
    No universal trough target.
    Gram-negative IP ceftazidime
    Long dwell 1–1.5 g once daily
    Short dwell 20 mg/kg once daily
    Alternatives: gentamicin 0.6 mg/kg daily (short courses; ototoxicity) or cefepime alone.
    Add-on · ISPD 1B Antifungal shield
    Oral nystatin 500,000 units four times daily or fluconazole 200 mg every 48 h, with any antibiotic course.
    Add-on · consider IP heparin
    500 units/L for cloudy effluent (fibrin occlusion). Analgesics as needed.
    Treat at home

    Stable, trained patient; IP antibiotics.

    Admit

    Fever, sepsis, significant pain, or unable to do PD at home.
    Sepsis/hypotension: resuscitate + systemic antibiotics.

    Memory hook
    VGram + CGram − IProute 6 hdwell +Fantifungal

    Exam trap: IV antibiotics in uncomplicated PD peritonitis.

  4. 4

    Stop 4 · Tailoring

    Organism-specific therapy and duration

    Duration follows the organism’s virulence.

    duration 2 wk CoNS · strep 3 wk tough 4

    2 weeks

    Coagulase-negative staphylococci and streptococci.

    3 weeks

    S. aureus, Pseudomonas, enterococci, Gram-negatives (enteric: at least 3 weeks).

    • Pseudomonas: two antipseudomonal drugs, different mechanisms, by sensitivity.
    • S. aureus: seek an exit-site or tunnel source.
    • Multiple Gram-positives: touch contamination.
    • Multiple Gram-negatives/mixed: intra-abdominal source; urgent surgical review + metronidazole.

    Culture-negative peritonitis

    72 h Repeat count + differential; special cultures (mycobacteria, Nocardia, fungi)

    Clearing

    Stop Gram-negative agent; Gram-positive alone, 2 weeks total.

    Not clearing

    Seek fungi/TB. Sterile, no improvement after day 5: remove; antibiotics ≥14 days after.

    Exam trap

    No extra week “to be safe”: more repeat peritonitis (15.0% vs 5.5%), more fungal risk.

  5. 5

    Stop 5 · Escalation

    Indications for catheter removal

    Failure to clear: remove the catheter, not more antibiotics.

    fungus: now DAY 5
    Fungal · immediate
    Yeast or Candida: remove now; oral/IV antifungal ≥2 weeks after removal.
    PD resumed in under one-third, median 15 weeks.
    Refractory · day 5
    Cloudy or WBC >100/µL after 5 days: remove, unless clearly falling.
    Catheter infection
    Pseudomonas + exit-site and tunnel infection: remove.
    S. aureus + exit-site/tunnel infection: consider.
    Same-organism exit-site/tunnel infection: suggested (ISPD 2023).
    Enteric · urgent
    Faecal or mixed enteric: surgical review + metronidazole.
    Remove if laparotomy finds pathology or abscess.
    Mycobacterial
    Non-tuberculous: removal suggested (2D). TB: anti-TB drugs, not removal.
    Memory hook

    “Fungus fast, refractory at five.”

  6. 6

    Stop 6 · Classification

    Relapsing, recurrent and repeat peritonitis

    4 weeks from the last day of antibiotics, not diagnosis.

    last dose 4 wk same different same
    Relapsing

    Same organism (or one sterile episode) within 4 weeks.

    Recurrent

    Different organism within 4 weeks; worse prognosis.

    Repeat

    Same organism after more than 4 weeks.

    Catheter-related: within 3 months of exit-site/tunnel infection, same organism (or one site sterile on antibiotics).

    Timely catheter removal

    Consider for relapsing, recurrent or repeat.

    Simultaneous removal and reinsertion

    Only if culture negative, WBC <100/µL, no exit-site/tunnel infection; perioperative antibiotics.
    Mainly staphylococcal relapse; enteric/Pseudomonas: remove, reinsert later.

    Memory hook

    Same-soon = relapsing · Different-soon = recurrent · Same-late = repeat.

    Long term

    Recurrent peritonitis + UF failure + bowel symptoms: EPS. Stop PD, move to HD.

  7. 7

    Stop 7 · Prevention

    Wet and dry contamination

    Classify first: it decides antibiotics.

    DRY clamp closed WET open · infused

    Dry contamination

    Closed system (distal to a closed clamp).
    Reassure, retrain, observe. No antibiotics.

    Wet contamination

    Fluid infused, or set left open.
    Change transfer set; effluent count + culture.
    Prophylaxis (2D): one IP cefazolin dose reasonable.

    Peritonitis followed only wet contamination (5.6%); prophylaxis cut risk.

    Memory hook

    “Not sure the clamp was shut? Call it wet.”

Pocket check

Rapid recall

Diagnostic criteria?

2 of 3: pain/cloudy effluent; WBC >100/µL, >50% neutrophils (≥2 h dwell); positive culture.

Effluent sampling?

5–10 mL into aerobic + anaerobic bottles, before antibiotics; lab within 6 h.

Empiric regimen and route?

IP vancomycin + ceftazidime, dwell ≥6 h, plus antifungal prophylaxis.

IP vancomycin dose?

CAPD 15–30 mg/kg every 5–7 days; APD 15 mg/kg every 4 days.

Duration by organism?

2 weeks CoNS/strep; 3 weeks S. aureus, Pseudomonas, enterococci, Gram-negatives.

Culture-negative at 72 h, clearing?

Stop Gram-negative agent; Gram-positive agent alone, 2 weeks total.

Refractory peritonitis?

Cloudy or WBC >100/µL after 5 days of appropriate antibiotics: remove catheter.

Fungal peritonitis?

Remove catheter now; systemic antifungal ≥2 weeks after removal.

Relapsing vs recurrent?

Same vs different organism, within 4 weeks of the last antibiotic day.

Wet contamination?

Change transfer set, effluent count + culture, prophylaxis (one IP cefazolin dose reasonable).

Next tabs: detail, spoken answer, viva questions.

Sources: ISPD peritonitis 2022 update (Li et al.); ISPD 2023 catheter-related infection.

📋

Case scenarios

Cases reported from real exam sittings.

Diagnose peritonitis (2 of 3). Drain and sample (cell count, Gram stain, culture). Start IP vancomycin + ceftazidime, add antifungal prophylaxis, consider IP heparin for cloudy effluent, analgesics as needed. Tailor to culture; duration by organism (2 vs 3 weeks).

Instill ~1 L, dwell 2 h, then drain and send the effluent for cell count, Gram stain and culture. Do not diagnose peritonitis without an effluent sample.

Fungal peritonitis: remove the catheter immediately and continue systemic antifungal for at least 2 weeks after removal; PD was resumed after a median of 15 weeks in under one-third of cases (ISPD 2022), with the timing individual after resolution. Do not attempt prolonged medical salvage.

Clear effluent with a normal cell count after an adequate dwell makes peritonitis unlikely (send a culture). Reduced drainage points to a leak or loculated fluid (or catheter malposition/constipation). Image (CT peritoneogram), treat constipation, reposition/flush catheter.

First assess haemodynamics (exclude hemorrhagic shock). Key causes to voice: peritonitis and menstruation/ovulation (most important); also anticoagulation, trauma, cyst rupture, polycystic kidney. Menstruation-related hemoperitoneum is usually self-limited.

Think of an exit-site granuloma and exclude exit-site/tunnel infection. For a granuloma: silver nitrate cauterisation, topical chlorhexidine or a silver ion-based dressing (ISPD 2023).

Step 1 — classify. Ask exactly what happened. DRY = the system stayed closed (disconnection distal to a closed clamp, no dialysate contact). WET = open system: fluid was infused after the contamination, or the catheter administration set was left open for a prolonged period. Examples of wet: leak from the dialysate bag, a leak or break in the tubing proximal to the clamp, breach of aseptic technique or touch contamination of the connection during an exchange. If the patient cannot confirm the clamp was shut, call it wet (ISPD 2022, benefit of the doubt).

Step 2 — if DRY: no prophylactic antibiotics. Reassure, review and retrain the exchange technique, and tell the patient to report pain, fever or cloudy fluid immediately.

Step 3 — if WET: (i) bring the patient in and change the sterile transfer set; (ii) send PD effluent for cell count with differential and culture even if asymptomatic; (iii) give prophylactic antibiotics — ISPD 2022 (2D) recommends prophylaxis after wet contamination but states there is no standard regimen; one dose of intraperitoneal cefazolin is a reasonable option. A short oral fluoroquinolone course was used historically but is now FDA-discouraged unless no alternative exists.

Step 4 — follow-up. Monitor closely for an extended period (a broader organism spectrum may follow, particularly in tropical centres). If any symptom appears, sample the effluent and start empiric IP antibiotics at once, without waiting for the results.

Step 5 — root cause. Audit the exchange technique, hand hygiene, the environment and the connectology; retrain, and log the event in the unit’s peritonitis-prevention audit.

Evidence to quote: in a series of 548 touch-contamination episodes cited by ISPD 2022, peritonitis occurred in 3.1% overall and only after wet contamination (5.6%), mostly coagulase-negative staphylococcal or culture-negative, and the risk fell significantly with prophylactic antibiotics.

Definition first: culture-negative peritonitis = the diagnostic criteria are met (abdominal pain and/or cloudy effluent + effluent WBC >100/uL with >50% neutrophils) but no organism is identified on effluent culture. If the source is clearly enteric, ISPD 2022 says classify it as enteric peritonitis, not culture-negative.

Ask why: recent antibiotic exposure, suboptimal sample collection or culture method, or a slow-growing atypical organism (mycobacteria, fungus). Non-infectious mimics: eosinophilic or chemical (icodextrin) peritonitis — check the differential. Hemoperitoneum is not peritonitis.

Fix the technique: inoculate 5–10 mL effluent at the bedside into both aerobic and anaerobic blood-culture bottles; for higher yield centrifuge 50 mL at 3000 g for 15 min and culture the pellet resuspended in 3–5 mL supernatant (5–10 fold yield increase); deliver within 6 h, incubate at 37°C if delayed, never refrigerate or freeze. ISPD target: culture-negative under 15% of all episodes (2C: review sampling and culture methods if above that); specialised centres achieve under 10%.

Day-3 algorithm: if there is no growth at 72 h, repeat the effluent cell count with differential and send a special culture request for mycobacteria, Nocardia, filamentous fungi and other fastidious bacteria; subculture on aerobic, anaerobic and microaerophilic media for a further 3–4 days. If improving → stop the Gram-negative agent and continue the Gram-positive agent alone (ISPD: the initial therapy is continued; Figure 10 example: stop gentamicin, continue cefazolin IP); total duration 2 weeks (outcomes at 2 and 3 weeks were similar). If not improving → special cultures and a search for fungi or mycobacteria; if still sterile with no improvement after day 5, remove the catheter and continue antibiotics for at least 14 days after removal (removal is required in about 10% of culture-negative episodes). Cure with antibiotics alone is 67.5–82.3%.

🎓

Viva Q&A

Key points from this topic, framed as questions you could be asked in the viva.
tap to reveal · self-test
Q1What are the diagnostic criteria for PD peritonitis?reveal
Two of three: abdominal pain and/or cloudy effluent; effluent WBC >100/uL with >50% neutrophils after a dwell of at least 2 hours; positive culture. The Gram stain guides early therapy (yeast) but is not the third criterion.
Q2The abdomen is dry (no dwell) — how do you exclude peritonitis?reveal
Instill about 1 L, dwell 2 hours, then drain and send the effluent for cell count with differential, Gram stain and culture.
Q3What empiric antibiotics do you start, and by which route?reveal
Intraperitoneal vancomycin (Gram-positive) plus ceftazidime (Gram-negative) after sampling; once-daily gentamicin is an alternative Gram-negative agent, chosen by the unit antibiogram, avoiding prolonged courses.
Q4What do you add besides antibiotics?reveal
consider IP heparin 500 U/L for cloudy effluent (may help prevent fibrin occlusion of the catheter), analgesics as needed, and antifungal prophylaxis (ISPD 2022) whenever an antibiotic course is given.
Q5What is the vancomycin dose in PD peritonitis?reveal
Intermittent IP 15-30 mg/kg every 5-7 days in CAPD, or 15 mg/kg every 4 days in APD, in a dwell of at least 6 hours (ISPD 2022 Table 5). ISPD 2022 sets no universal trough target; repeat dosing follows levels and the local protocol.
Q6How long do you treat, by organism?reveal
2 weeks for coagulase-negative staph and streptococci; 3 weeks for S. aureus, Pseudomonas, enterococci and other Gram-negatives; enteric Gram-negative and polymicrobial peritonitis are treated for at least the same 3 weeks. With multiple Gram-positive organisms I treat by sensitivities and think touch contamination; with multiple Gram-negative or mixed organisms I think intra-abdominal source, ask for urgent surgical assessment and add metronidazole, with catheter removal if laparotomy is needed.
Q7When do you remove the PD catheter?reveal
Refractory (still cloudy or WBC above 100/uL at 5 days), fungal peritonitis; fecal/enteric peritonitis when laparotomy is needed. ISPD suggests removal (2D) for non-tuberculous mycobacterial peritonitis, and (2C) for an exit-site or tunnel infection that progresses to, or occurs with, peritonitis from the same organism. I consider timely removal for relapsing, recurrent or repeat peritonitis. Tuberculous peritonitis is treated with anti-TB drugs instead of removal.
Q8Yeast is seen on Gram stain — what now?reveal
Fungal peritonitis: remove the catheter immediately and continue systemic antifungal for at least 2 weeks after removal (ISPD 2022); in fungal peritonitis PD was resumed after a median of 15 weeks, in under one-third of cases (ISPD 2022), with the timing individual after resolution.
Q9Why does ISPD 2022 recommend antifungal prophylaxis?reveal
Any antibiotic course predisposes to secondary fungal peritonitis, so oral nystatin or fluconazole is given during the course (1B) to prevent it.
Q10A PD patient has abdominal pain but clear effluent and normal cell count — is this peritonitis?reveal
Not by the two-of-three criteria yet (only the pain criterion is met): I send a cell count and culture, and look for constipation (treat with laxatives), catheter malfunction/outflow obstruction, leak or loculated fluid; peritonitis stays in the differential of abdominal pain even with clear effluent, so I rule it out only with a normal cell count after an adequate dwell and a negative culture.
Q11Why increasing peritonitis rates in your unit, and how do you prevent it?reveal
Usually touch contamination/technique lapse, exit-site infection, or training gaps; prevent with retraining, exit-site antibiotic prophylaxis, hand hygiene, treating constipation, and audit against ISPD benchmarks.
Q12Recurrent peritonitis over several years with UF failure and bowel symptoms — what do you fear?reveal
Encapsulating peritoneal sclerosis (EPS): stop PD, switch to HD, optimise nutrition, and consider tamoxifen +/- corticosteroids (evidence anecdotal).
Q13Define recurrent, relapsing, repeat, refractory and catheter-related peritonitis (ISPD 2022).reveal
The clock always runs from completion of therapy — the LAST day of antibiotics.
RELAPSING: an episode within 4 weeks of completing therapy with the SAME organism, or where one of the two episodes is sterile (culture-negative).
RECURRENT: an episode within 4 weeks of completing therapy with a DIFFERENT organism — worse prognosis than relapsing.
REPEAT: an episode MORE than 4 weeks after completing therapy with the SAME organism.
REFRACTORY: persistently cloudy bags or effluent leukocyte count above 0.1 x10^9/L (>100/uL) after 5 days of appropriate antibiotics.
CATHETER-RELATED: peritonitis occurring in temporal conjunction — within 3 months — with an exit-site or tunnel infection, with the same organism at both sites, or one site sterile in the context of antibiotic exposure.
Relapsing, recurrent and repeat episodes all warrant consideration of timely catheter removal (1C).
Q14A patient phones after a break in sterile technique during an exchange — take me through it A to Z.reveal
First classify it.
DRY contamination = contamination outside a closed system, e.g. a disconnection distal to a closed clamp.
WET contamination = an open system: dialysis fluid was infused after the contamination, or the administration set was left open for a prolonged period — for example a leak from the bag, a leak or break in the tubing proximal to the clamp, or touch contamination of the connection. If I cannot confirm the clamp was closed, I call it wet.
Dry: no antibiotics — reassure, retrain the technique, ask them to report pain, fever or cloudy fluid.
Wet: bring the patient in, change the sterile transfer set, send effluent for cell count with differential and culture even if asymptomatic, and give prophylactic antibiotics — ISPD 2022 (2D) recommends prophylaxis after wet contamination but states there is no standard regimen; one dose of intraperitoneal cefazolin is a reasonable option (oral fluoroquinolones are now FDA-discouraged). Then monitor closely for an extended period and audit the exchange technique. In the 548-episode series ISPD cites, peritonitis followed only wet contamination — 5.6%, versus 3.1% overall — and prophylactic antibiotics significantly reduced it.
Q15Does DRY contamination need prophylactic antibiotics?reveal
No. ISPD 2022 recommends prophylactic antibiotics only after WET contamination. Dry contamination means contamination outside a closed system, so antibiotics are not recommended — reassure, retrain and observe. If it is unclear whether the clamp was open or closed, treat it as wet.
Q16The cultures come back negative — what do you do?reveal
Culture-negative peritonitis means the criteria are met but no organism grew. At 72 h with no growth I repeat the effluent cell count with differential and request special cultures for mycobacteria, Nocardia, filamentous fungi and other fastidious bacteria, with subculture on aerobic, anaerobic and microaerophilic media for a further 3-4 days.
If the effluent is clearing the organism was probably Gram-positive: I stop the Gram-negative agent and continue the Gram-positive agent alone (ISPD: the initial therapy is continued; Figure 10 example: stop gentamicin, continue cefazolin IP for 14 days) for a total of 2 weeks — 3 weeks gives no better outcome.
If it is not improving I send special cultures and look for fungi or mycobacteria; if it is still sterile with no improvement after day 5, I remove the catheter and continue antibiotics for at least 14 days after removal. Removal is needed in about 10% of culture-negative episodes.
I also exclude non-infectious mimics — eosinophilic or icodextrin-related chemical peritonitis — on the differential.
Q17What is an acceptable culture-negative rate and how do you reduce it?reveal
ISPD 2022 sets the target at under 15% of all peritonitis episodes, reported yearly, and suggests (2C) reviewing sampling and culture methods if you exceed it; specialised centres reach under 10%.
To reduce it: inoculate
  • 5-10 mL of effluent at the bedside into both aerobic and anaerobic blood-culture bottles
  • for higher yield centrifuge 50 mL at 3000 g for 15 minutes and culture the pellet resuspended in 3-5 mL of supernatant, which raises the yield 5-10 fold
  • get the specimen to the laboratory within 6 hours, incubate at 37 C if delayed, and never refrigerate or freeze the bottles.
Recent antibiotic use and improper culture technique are recognised risk factors.
Q18When can you replace the catheter in relapsing peritonitis instead of transferring to HD?reveal
Simultaneous catheter removal and reinsertion is an option, but only once the effluent culture has become negative and the effluent white cell count is below 100/uL, and only if there is no concomitant exit-site or tunnel infection (ISPD 2022, 2C), done under perioperative antibiotic cover. It is mainly for Staphylococcal relapse; after enteric or Pseudomonas relapse I remove first and reinsert later. Doing it before the culture is negative risks reseeding from planktonic bacteria.
Q19A relapsing episode grows S. aureus, or enterococci or a Gram-negative. What do you look for besides removing the catheter?reveal
The source. A recurrent S. aureus infection should trigger a search for pericatheter infection (exit site and tunnel). With enterococci or Gram-negative organisms I consider intra-abdominal disease or an abscess (enterococci are often enteric in origin), and I investigate any bowel-habit change or other gastrointestinal symptom.
Coagulase-negative staphylococci form biofilm on the catheter, which is why they can relapse.
Q20The effluent white count is high but eosinophils predominate and the culture is negative. What is it and what do you do?reveal
Eosinophilic (allergic) peritonitis, diagnosed from the effluent cell type. It can be a reaction to the PD solution or tubing, and icodextrin is another recognised cause. I avoid the causative agent if one is identifiable. I do not label it culture-negative bacterial peritonitis.
Q21A PD patient is booked for a colonoscopy or hysteroscopy. How do you protect against peritonitis?reveal
ISPD 2022 suggests antibiotic prophylaxis before colonoscopy (2C) and invasive gynaecological procedures such as hysteroscopy (2D), and draining the PD fluid to keep the abdomen empty before endoscopic GI and invasive gynaecological procedures (2D). Routine prophylaxis before dental work is not an ISPD recommendation; ISPD lists it as a research gap.
Q22A PD patient on a calcium channel blocker has cloudy effluent, but the peritonitis work-up is normal (effluent WBC below 100/uL, culture negative). What do you suspect and what do you do?reveal
Sterile cloudy effluent, so I do not treat it as peritonitis.
Chylous effluent is the key suspect: chylomicrons make the fluid cloudy, and calcium channel blockers are a recognised cause (the Handbook lists dihydropyridine blockers among the causes of turbid fluid). I send the effluent for triglycerides, cell differential (eosinophils) and cytology, and I check the sample was not taken from a dry abdomen or full of fibrin.
If it is chylous I review the drug and consider changing the antihypertensive, and I look for other causes of sterile cloudy effluent: lymphatic obstruction, acute pancreatitis, lymphoma or other malignancy.
Q23Give five measures that prevent PD peritonitis.reveal
1) Training: thorough initial training of patient and caregiver, and retraining after every peritonitis episode.
2) Connection technique: in CAPD, a disconnect system with a flush-before-fill design (1A), since touch contamination of the connection is the commonest cause.
3) Catheter insertion: systemic antibiotic prophylaxis immediately before insertion.
4) Exit site: daily topical antibiotic at the exit site (gentamicin 0.1% cream is the one the Handbook names; mupirocin is the other option) and prompt treatment of any exit-site infection.
5) Cover for procedures: antibiotic prophylaxis before colonoscopy and invasive gynaecological procedures.
I add oral nystatin or fluconazole whenever an antibiotic course is given, give prophylactic antibiotics after wet contamination, and treat constipation. I audit the unit's peritonitis rate against ISPD targets.
Q24How do you diagnose eosinophilic (allergic) PD peritonitis and what is the empirical treatment?reveal
The effluent is cloudy with a raised WBC in which eosinophils predominate on the differential, and the cultures are negative.
The Handbook lists it among the causes of turbid fluid and says it may be an allergic reaction to the PD solution or tubing. Because I cannot separate it from bacterial peritonitis at presentation, I sample and start the standard empirical intraperitoneal antibiotics. If the effluent does not clear I resend for special cultures (fungi, mycobacteria, virus) and consider other causes: an allergic reaction to the dialysate (icodextrin) or a drug, or malignancy or lymphoproliferative disease.
Catheter-removal indications are the same as for any peritonitis: refractory, fungal, faecal needing laparotomy, or (suggested) non-tuberculous mycobacterial, with timely removal considered for relapsing episodes.
🗣

Spoken approach

say this aloud
🧠 Self-test — say each step from its label, then tap it to check.
  1. Opening: This is a PD patient with abdominal pain, fever and cloudy effluent; my priority is to sample the effluent before antibiotics and treat it as peritonitis until proven otherwise.
  2. Stabilise: I check vital signs for sepsis; I admit if there is fever, sepsis, significant pain or the patient cannot do PD at home; otherwise a stable, trained patient is treated at home. Antibiotics go intraperitoneally unless there are features of systemic sepsis.
  3. History: I ask about abdominal pain, fever, exit-site or tunnel changes, recent connection breaks, constipation and diarrhoea.
  4. Examination: I examine the abdomen, and the exit site and tunnel for a source.
  5. Labs: I drain the dwell and send cell count with differential, Gram stain and culture in blood-culture bottles before antibiotics; blood cultures if septic or immunosuppressed. If the abdomen is dry, I instill about 1 L, dwell 2 hours, then drain and sample.
  6. Imaging & specific tests: I inoculate 5-10 mL into aerobic and anaerobic bottles at the bedside, to the lab within 6 hours; for higher yield I centrifuge 50 mL at 3000 g for 15 minutes and culture the pellet.
  7. Diagnosis: I need 2 of 3: abdominal pain and/or cloudy effluent, effluent WBC above 100/uL with more than 50% neutrophils after at least a 2-hour dwell, positive culture. The culture may be pending, so the first two are enough — only now do I say peritonitis.
  8. Treatment: Straight after sampling, intraperitoneal vancomycin plus ceftazidime, dwell at least 6 hours: vancomycin 15-30 mg/kg every 5-7 days in CAPD, 15 mg/kg every 4 days in APD; ceftazidime 1-1.5 g once daily in a long dwell. Once-daily gentamicin is an alternative Gram-negative agent; the unit antibiogram decides.
  9. Treatment — adjuncts: consider IP heparin 500 units/L for cloudy effluent (may help prevent fibrin occlusion of the catheter), analgesics as needed, and antifungal prophylaxis with oral nystatin or fluconazole during any antibiotic course (ISPD 2022).
  10. Treatment — duration: I tailor to culture: 2 weeks for coagulase-negative staph and streptococci; 3 weeks for S. aureus, Pseudomonas, enterococci and Gram-negatives. I do not extend to be safe — one extra week gave more repeat peritonitis, and longer courses raise the fungal risk.
  11. Treatment — culture-negative: At 72 hours with no growth I repeat the cell count with differential and request special cultures for mycobacteria, Nocardia and fungi. If clearing, I stop the Gram-negative agent and continue the Gram-positive agent alone, 2 weeks in total (ISPD Figure 10 example: stop gentamicin, continue cefazolin IP for 14 days); if still sterile with no improvement after day 5, I remove the catheter and continue antibiotics for at least 14 days after removal.
  12. If it fails: Still cloudy or effluent WBC above 100/uL at 5 days is refractory, so I remove the catheter, unless the count is clearly falling toward normal. Fungal means remove immediately with systemic antifungal for at least 2 weeks after removal. For non-tuberculous mycobacteria ISPD suggests removal (2D), but TB is treated with anti-TB drugs instead; faecal peritonitis needs surgical review.
  13. If it fails — replacement: For relapsing, recurrent or repeat peritonitis I consider timely catheter removal; simultaneous removal and reinsertion only once culture is negative, WBC below 100/uL and there is no exit-site or tunnel infection; this single-stage option is mainly for Staphylococcal relapse, while after enteric or Pseudomonas relapse I remove first and reinsert later.
  14. Classification: The clock runs from the last day of antibiotics. Relapsing: same organism, or one sterile episode, within 4 weeks; recurrent: different organism within 4 weeks; repeat: same organism after more than 4 weeks.
  15. Classification — catheter-related: Catheter-related means within 3 months of an exit-site or tunnel infection, same organism or one site sterile on antibiotics.
  16. Contamination call: If a patient phones after a break, I classify first. Dry means the system stayed closed: reassure, retrain, no antibiotics. Wet means fluid infused or the set left open, and if unsure I call it wet.
  17. Contamination call — wet: I change the sterile transfer set, send effluent cell count and culture, and give prophylactic antibiotics — ISPD 2022 has no standard regimen; one IP cefazolin dose is reasonable — then monitor closely.
  18. Follow-up: I find the root cause — touch contamination, exit-site infection, constipation — and reinforce prevention; the culture-negative target is under 15% of episodes. Recurrent peritonitis over years with UF failure and bowel symptoms raises EPS: stop PD and move to HD.
⤴

Escalation ladder

and if that fails?

Cloudy effluent → sample → empiric IP vancomycin + ceftazidime + antifungal prophylaxis + consider IP heparin → tailor to culture.

And if it fails? Still cloudy or effluent WBC >100/uL at 5 days = refractory → remove the catheter (do not persist with antibiotics; longer observation only if the count is clearly falling toward normal). Fungal (yeast on Gram stain) → remove now + systemic antifungal for at least 2 weeks after catheter removal; in fungal peritonitis PD was resumed after a median of 15 weeks, in under one-third of cases (ISPD 2022), with the timing individual after resolution. Relapsing, recurrent or repeat → consider timely removal; simultaneous replacement only once the culture is negative and the WBC is <100/uL (mainly for Staphylococcal relapse; after enteric or Pseudomonas relapse remove first and reinsert later). Fecal/enteric → urgent surgical review + anaerobic cover (metronidazole); the catheter is usually removed if laparotomy is needed. TB → anti-TB drugs, not removal; non-tuberculous mycobacteria → antibiotics + removal (suggested, 2D).

Recurrent peritonitis over years → think EPS (bloody/turbid effluent, UF failure, bowel obstruction) → stop PD, switch to HD, nutrition, +/- tamoxifen/steroids (evidence anecdotal).

Cultures still sterile at 72 h? Do not just carry on. Repeat effluent cell count with differential and request special cultures (mycobacteria, Nocardia, filamentous fungi, other fastidious bacteria); subculture aerobic/anaerobic/microaerophilic for a further 3–4 days. Effluent clearing → stop the Gram-negative agent, continue the Gram-positive agent alone, total 2 weeks (3 weeks adds nothing). Not improving → special cultures; still sterile with no improvement after day 5 → remove the catheter and continue antibiotics for at least 14 days after removal (removal is needed in about 10% of culture-negative episodes). ISPD 2022 reports ampicillin–sulbactam plus amikacin as a salvage regimen in a small series.

Contamination call, not peritonitis? Classify first. DRY (system stayed closed, break distal to a closed clamp) → reassure, retrain, observe — no antibiotics. WET (fluid infused after the break, or the set left open; or you cannot confirm the clamp was shut) → change the sterile transfer set + send effluent cell count and culture + prophylactic antibiotics (ISPD 2022, 2D; one IP cefazolin dose is reasonable) → monitor closely for an extended period.

💊

Management

Diagnose and start empiric IP antibiotics
Confirm the diagnosis
  • 2 of 3: abdominal pain and/or cloudy effluent; effluent WBC >100/uL with >50% PMN (dwell >=2 h); positive culture
  • Dry abdomen: instill ~1 L, dwell 2 h, drain and sample
  • Send cell count/differential, Gram stain, culture BEFORE antibiotics, then start antibiotics at once without waiting for results
Empiric intraperitoneal antibiotics
  • Vancomycin (Gram-positive) + ceftazidime (Gram-negative), intraperitoneal, dwell >=6 h
  • Vancomycin IP 15-30 mg/kg every 5-7 days (CAPD) or 15 mg/kg every 4 days (APD), no universal trough target; ceftazidime 1000-1500 mg once daily (long dwell) or 20 mg/kg daily (short dwell)
  • Gentamicin 0.6 mg/kg once daily is an accepted alternative Gram-negative agent (ISPD: third-generation cephalosporin or aminoglycoside) (short courses do not speed loss of residual function); avoid prolonged courses (ototoxicity). The unit antibiogram decides; cefepime alone is another option
  • Add antifungal prophylaxis (nystatin/fluconazole); consider IP heparin 500 U/L for cloudy effluent (may help prevent fibrin occlusion)
Tailor by culture, duration and removal
Organism-directed duration
  • Coagulase-negative staph / streptococci: 2 weeks
  • S. aureus, Pseudomonas, enterococci, Gram-negatives: 3 weeks
  • Enteric Gram-negative: at least 3 weeks. Polymicrobial: multiple Gram-positive organisms → treat by sensitivities for at least 3 weeks and think touch contamination; multiple Gram-negative or mixed organisms → think intra-abdominal source, urgent surgical assessment, add metronidazole, at least 3 weeks; remove the catheter if laparotomy shows intra-abdominal pathology or abscess
  • Culture-negative improving: stop the Gram-negative agent, continue the Gram-positive agent already running alone (ISPD: the initial therapy is continued; Figure 10 example: stop gentamicin, continue cefazolin IP for 14 days) to 2 weeks in total; not improving -> hunt fungi/TB
  • Do NOT extend beyond the ISPD duration 'to be safe' — an RCT of one extra week showed no reduction in relapsing/recurrent peritonitis and more repeat peritonitis; prolonged antibiotics also raise the risk of secondary fungal peritonitis
  • Pseudomonas: two antipseudomonal antibiotics with different mechanisms, chosen by sensitivity, for 3 weeks; Stenotrophomonas: trimethoprim-sulfamethoxazole-based, two different classes of antibiotics, for at least 3 weeks; after S. aureus peritonitis, look for an exit-site or tunnel source
Catheter removal indications
  • Refractory: still cloudy or effluent WBC >100/uL after 5 days of appropriate antibiotics (longer observation acceptable if the count is clearly falling)
  • Relapsing (same organism within 4 weeks) / recurrent — consider timely removal
  • Fungal peritonitis — remove immediately
  • Fecal/enteric peritonitis needing laparotomy (low threshold to remove for enteric Gram-negatives resistant to cephalosporins or fluoroquinolones); non-tuberculous mycobacteria (ISPD suggests removal, 2D; TB is treated with anti-TB drugs instead of removal); exit-site/tunnel infection that progresses to, or occurs with, peritonitis from the same organism (ISPD 2023 suggests removal, 2C)
  • Relapsing, recurrent OR repeat peritonitis — consider timely catheter removal (ISPD 2022, 1C)
  • Simultaneous removal and reinsertion is an option only once the effluent culture is negative, effluent WBC is below 100/uL and there is no exit-site or tunnel infection (2C), under perioperative antibiotic cover; single-stage replacement is mainly for Staphylococcal relapse, whereas after enteric or Pseudomonas relapse remove first and reinsert later
  • Culture-negative peritonitis still not improving after day 5 — remove and continue antibiotics for at least 14 days after removal; about 10% of all culture-negative episodes need removal
  • Pseudomonas peritonitis with a concomitant exit-site and tunnel infection: remove the catheter (ISPD 2022, 2D); S. aureus peritonitis with an exit-site or tunnel infection: consider removal
  • Other indications: mechanical catheter failure (malposition, fibrin, adhesions or loculation) when conservative steps fail (laxatives or enemas, saline flush or fibrinolytic, surgical repositioning or lysis of adhesions, eventually catheter replacement); isolated exit-site or tunnel infection that fails antibiotics → simultaneous replacement at a new exit site, or surgical salvage (cuff shaving) in selected patients; ISPD 2023 (1C): avoid simultaneous removal and reinsertion when there is deep Dacron cuff involvement or concurrent peritonitis; for catheter infection with concurrent peritonitis, ISPD 2023 advises temporary haemodialysis with no reinsertion until at least 2 weeks after catheter removal and complete resolution of peritonitis
Pharmacology
AgentRoleDose / route
VancomycinEmpiric Gram-positiveIntermittent IP: 15-30 mg/kg every 5-7 days (CAPD); 15 mg/kg every 4 days (APD); dwell ≥6 h; ISPD 2022 sets no universal trough target
CeftazidimeEmpiric Gram-negativeIntermittent IP: 1000-1500 mg once daily (long dwell) or 20 mg/kg once daily (short dwell)
GentamicinAlternative Gram-negative0.6 mg/kg IP once daily; continuous dosing not advised; avoid prolonged courses (ototoxicity)
IP heparinConsider for cloudy effluent: may help prevent fibrin occlusion of the catheter500 units/L in each bag
Antifungal prophylaxisPrevent fungal peritonitis (ISPD 2022)Oral nystatin 500,000 units four times daily, or fluconazole 200 mg every 48 h, during any antibiotic course
Fluconazole/echinocandinFungal peritonitis (+ remove catheter)Oral or IV antifungal (oral/IV preferred; IP dosing exists but is not preferred) ≥ 2 weeks after catheter removal
CefazolinProphylaxis after WET contamination (ISPD 2022, 2D)One intraperitoneal dose is a reasonable option — ISPD states there is no standard regimen; oral fluoroquinolones were used previously but are now FDA-discouraged
Ampicillin–sulbactam + amikacinReported salvage for culture-negative peritonitis with a suboptimal initial responseSmall series only (response in 8 of 10 cases) — cited by ISPD 2022, not a graded recommendation
⚡

Quick reference

numbers at a glance
Diagnosis2 of 3: pain and/or cloudy fluid, WBC >100 (>50% PMN, dwell ≥2 h), positive culture
Dry abdomenInstill ~1 L, dwell 2 h, drain and sample
Empiric IPVancomycin + ceftazidime (or once-daily gentamicin; the unit antibiogram decides)
Vancomycin15-30 mg/kg IP every 5-7 d (CAPD); 15 mg/kg every 4 d (APD)
AdjunctsConsider IP heparin 500 U/L, antifungal prophylaxis (ISPD 2022), analgesics as needed
Duration2 wk CoNS/strep; 3 wk S. aureus/Pseudomonas/enterococci/GNB
Remove catheterRefractory (5 d), fungal; ISPD suggests removal (2D) for non-tuberculous mycobacteria and (2C) for exit-site/tunnel infection with same-organism peritonitis; consider for relapsing/recurrent/repeat; TB = anti-TB drugs, not removal
FungalRemove now + antifungal ≥2 wk after removal; PD resumed after a median of 15 wk in under one-third of cases (ISPD 2022), timing individual after resolution
RelapsingSame organism (or one sterile episode) within 4 wk of the LAST antibiotic dose
RecurrentDifferent organism within 4 wk of the last dose — worse prognosis
RepeatSame organism more than 4 wk after the last dose
RefractoryStill cloudy / effluent WBC >100/uL after 5 days of appropriate antibiotics
Catheter-relatedWithin 3 months of an exit-site/tunnel infection, same organism (or one site sterile)
Re-insertionSimultaneous removal + reinsertion once culture negative, WBC <100/uL, no ESI/tunnel infection
Dry contaminationClosed system → no antibiotics, retrain, observe
Wet contaminationOpen system / fluid infused / unsure → transfer-set change + effluent culture + prophylaxis (1 IP cefazolin dose)
Culture-negativeTarget <15% of episodes; 5–10 mL into aerobic + anaerobic bottles; centrifuge 50 mL at 3000 g x 15 min
Day 3, no growthRepeat cell count + special cultures (TB, Nocardia, fungi); improving → stop Gram-negative agent, Gram-positive alone, 2 wk total; still sterile and not improving after day 5 → remove + antibiotics at least 14 d after removal
⚑

Red flags

must not miss
  • Yeast on Gram stain / Candida — remove the catheter immediately, do not wait
  • Fecal odour or multiple enteric organisms — suspect bowel perforation; urgent surgical review
  • No improvement (persistently cloudy, high WBC) at day 5 — refractory; remove catheter
  • Systemic sepsis / hypotension — resuscitate, add systemic antibiotics, admit
  • Recurrent peritonitis over years with UF failure and GI symptoms — EPS
  • Patient reports a WET contamination (fluid infused after the break, or the set left open) — transfer-set change plus prophylactic antibiotics and an effluent sample; do not just reassure over the phone
  • Clamp status uncertain during a contamination — treat as wet, for the benefit of the doubt (ISPD 2022)
  • Unit culture-negative rate above 15% of episodes — review sampling and culture technique (and recent antibiotic use): treatable organisms may be missed
  • Second episode with the SAME organism within 4 weeks of finishing antibiotics — relapsing peritonitis; consider timely catheter removal rather than another antibiotic course
🧭

Flowchart

memorize this
graph TD;
A["PD patient, cloudy effluent or abdominal pain"] --> B{"Abdomen has a dwell?"};
B -->|No, dry| C["Instill ~1 L, dwell 2 h, then drain"];
B -->|Yes| D["Drain and sample"];
C --> D;
D --> E["Cell count, Gram stain, culture"];
E --> G["Start empiric IP vancomycin + ceftazidime at once, add antifungal prophylaxis, consider IP heparin"];
G --> F{"2 of 3 criteria confirmed?"};
F -->|"No: clear fluid, normal count, culture negative"| N["Stop antibiotics, consider constipation, catheter malfunction, leak or loculated fluid"];
F -->|Yes| H{"Culture result"};
H -->|Yeast/fungal| I["Remove catheter now + antifungal at least 2 weeks after removal"];
H -->|Bacterial| J["Tailor antibiotics, duration by organism (2 or 3 weeks)"];
J --> K{"Clear by day 5?"};
K -->|No, WBC not falling| L["Refractory, remove catheter"];
K -->|Yes| M["Complete course, review source and prevention"];
H -->|No growth at day 3| O["Repeat cell count with differential, special cultures for mycobacteria, Nocardia, fungi"];
O --> P{"Clinical improvement?"};
P -->|Yes| Q["Stop the Gram-negative agent, Gram-positive agent alone, total 2 weeks"];
P -->|No, still sterile after day 5| L2["Remove catheter, antibiotics at least 14 days after removal"];
R["Contamination during an exchange, no symptoms yet"] --> S{"Wet or dry contamination?"};
S -->|Dry, system stayed closed| T["No prophylactic antibiotics, retrain technique, observe"];
S -->|Wet, or clamp status unknown| U["Change the sterile transfer set, send effluent cell count and culture, one IP cefazolin dose"];
U --> V["Monitor closely, if pain, fever or cloudy fluid appear, sample and start empiric IP antibiotics"];
◈

Exam traps & pitfalls

where marks are lost
  • Giving antibiotics IV instead of intraperitoneal for uncomplicated PD peritonitis
  • Starting antibiotics before sending cell count, Gram stain and culture
  • Giving prolonged aminoglycoside courses (ototoxicity) — a short once-daily gentamicin course is acceptable and does not speed loss of residual function
  • Forgetting antifungal prophylaxis (ISPD 2022) and the antifungal-plus-removal rule for fungal peritonitis
  • Persisting with antibiotics in refractory peritonitis instead of removing the catheter at day 5
  • Calling every abdominal pain 'peritonitis' — missing constipation or catheter malfunction
  • Treating every contamination call the same — dry contamination needs no antibiotics; wet contamination needs a transfer-set change, an effluent sample and prophylaxis
  • Calling an episode 'recurrent' when the organism is the same — that is relapsing; recurrent means a DIFFERENT organism within 4 weeks
  • Dating the 4-week window from the day of diagnosis instead of the last day of antibiotics
  • Accepting a high culture-negative rate as bad luck instead of auditing sample volume, blood-culture bottles, centrifugation and transport time
  • Extending antibiotics an extra week 'to be safe' — no benefit, more repeat peritonitis, and a higher fungal risk
  • Attempting simultaneous catheter removal and reinsertion before the effluent culture is negative and the WBC is below 100/uL
  • Relying on intraperitoneal antifungal salvage for fungal peritonitis - the catheter comes out and the antifungal is oral or intravenous (oral/IV preferred; IP dosing exists but is not preferred)
  • Removing the catheter for tuberculous peritonitis — TB is treated with anti-TB drugs; catheter removal is suggested for non-tuberculous mycobacteria
🔬

Differential

Cloudy effluent — infectious
  • Bacterial peritonitis (Gram-positive: coagulase-negative staph, S. aureus; Gram-negative: E. coli, Pseudomonas)
  • Fungal peritonitis (Candida) — often after antibiotic courses
  • Mycobacterial / culture-negative peritonitis
Cloudy effluent — non-infectious
  • Chemical/eosinophilic peritonitis (icodextrin, reaction to PD solution or tubing, eosinophils on differential)
  • Chylous effluent; malignancy
  • Hemoperitoneum (blood-tinged) — menstruation/ovulation, cyst rupture, anticoagulation, trauma
Abdominal pain in a PD patient (not always peritonitis)
  • Constipation (common; treat with laxatives — can also cause outflow failure)
  • Catheter-tip malposition / outflow obstruction; inflow pain
  • Surgical abdomen, EPS (long PD vintage, especially after severe or recurrent peritonitis), pancreatitis
🔑

Examiner keywords

the words he waits for
cloudy effluentfirst sign of PD peritonitis, sample before treatingWBC >100 with >50% neutrophilseffluent threshold that strongly suggests peritonitis (one of the diagnostic criteria)2 of 3 criteriapain and/or cloudy fluid, effluent WBC/PMN, positive culturesample before antibioticscell count, Gram stain, culture firstIP vancomycin + ceftazidimeempiric Gram-positive plus Gram-negative coverantifungal prophylaxisISPD 2022 (1B) with any antibiotic courseconsider IP heparin 500 U/Lmay help prevent fibrin from blocking the catheterduration by organism2 weeks CoNS/strep, 3 weeks S. aureus/Pseudomonas/GNBfungal = remove catheter nowimmediate removal plus systemic antifungalrefractory at 5 daysfailure to clear means remove the catheterrelapsing versus recurrentsame organism within 4 weeks is relapsing, a different organism within 4 weeks is recurrent; swapping them loses the markrepeat peritonitissame organism but more than 4 weeks after completing therapy, a separate ISPD categorycompletion of therapythe 4-week clock runs from the last day of antibiotics, not from the day of diagnosiscatheter-related peritonitisperitonitis within 3 months of an exit-site or tunnel infection with the same organism, or one site sterile on antibioticswet versus dry contaminationthe first thing to establish in any contamination call because it decides whether antibiotics are givenopen system, fluid infusedthe ISPD definition of wet contamination; if the clamp status is unknown, call it wetchange the sterile transfer setthe core mechanical step after wet contaminationone dose of IP cefazolina reasonable prophylactic option after wet contamination (ISPD 2022, 2D; no standard regimen)culture-negative under 15%the ISPD reporting target; above it, review your sampling and culture technique firstblood-culture bottles, 5-10 mL, aerobic and anaerobiccorrect bedside inoculation that lowers the culture-negative ratecentrifuge 50 mL at 3000 g for 15 minutesconcentration step that raises culture yield 5-10 foldday-3 reassessmentrepeat cell count with differential plus special cultures for mycobacteria, Nocardia and fungi if nothing has grownimproving but sterilestop the Gram-negative agent and continue the Gram-positive agent, 2 weeks in total; 3 weeks adds nothing
🔎

Investigations & data

  • Effluent cell count + differential — WBC >100/uL with >50% neutrophils supports peritonitis; in rapid-cycle APD use the percentage: >50% neutrophils strongly suggests peritonitis even if WBC <100/uL
  • Effluent Gram stain and culture (blood-culture bottles; centrifuge to raise yield) — guides organism-specific therapy
  • Peripheral blood cultures if systemically septic or immunosuppressed
  • Exit-site swab if discharge; assess tunnel
  • Effluent differential for eosinophils (chemical/eosinophilic) or RBCs (hemoperitoneum)
  • If culture-negative and not improving: special cultures for mycobacteria/fungi, consider imaging
  • Correct culture technique (ISPD 2022): bedside inoculation of 5-10 mL effluent into BOTH aerobic and anaerobic blood-culture bottles; specimen to the laboratory within 6 h; if delayed, incubate the bottles at 37 C — never refrigerate or freeze
  • Large-volume method to cut the culture-negative rate: centrifuge 50 mL effluent at 3000 g for 15 min, resuspend the sediment in 3-5 mL supernatant and culture the pellet — raises yield 5-10 fold (ISPD 2022)
  • No growth at day 3: repeat effluent cell count with differential PLUS special culture request for mycobacteria, Nocardia, filamentous fungi and other fastidious bacteria; subculture aerobic/anaerobic/microaerophilic for a further 3-4 days
  • Send effluent for cell count and culture after any WET contamination even if the patient is asymptomatic (ISPD 2022)
Reading the data
FindingInterpretation
Cloudy fluid + WBC >100/uL, >50% neutrophilsPeritonitis (2 of 3 criteria — culture may still be pending)
Yeast on Gram stain / Candida on cultureFungal peritonitis — remove catheter now + systemic antifungal
Multiple enteric organisms / fecal odourPossible intra-abdominal source — urgent surgical review and anaerobic cover; the catheter is usually removed if laparotomy is needed
Eosinophils predominate, cultures negativeEosinophilic/chemical peritonitis (icodextrin, reaction to PD solution or tubing)
Blood-stained effluent in a menstruating womanHemoperitoneum from menstruation/ovulation — usually self-limited
No improvement (still cloudy, WBC high) at day 5Refractory peritonitis — remove catheter (longer observation is acceptable only if the count is clearly falling toward normal)
New episode, SAME organism, within 4 weeks of the last dose of antibioticsRelapsing (also counts if one of the two episodes was culture-negative)
New episode, DIFFERENT organism, within 4 weeks of the last doseRecurrent — worse prognosis than relapsing
New episode, SAME organism, more than 4 weeks after the last doseRepeat peritonitis
Peritonitis within 3 months of an exit-site/tunnel infection, same organism (or one site sterile on antibiotics)Catheter-related peritonitis
Peritonitis criteria met but no organism grownCulture-negative peritonitis — ISPD target is under 15% of all episodes
No growth at 72 h but effluent clearingLikely Gram-positive; stop the Gram-negative agent and continue the Gram-positive agent already running alone, total duration 2 weeks (ISPD: the initial therapy is continued; Figure 10 example: gentamicin stopped, cefazolin IP continued for 14 days)
Unit culture-negative rate above 15% of episodesReview sampling and culture technique first (ISPD 2022, 2C); also consider recent antibiotics and atypical organisms
Contamination with the clamp CLOSED, no fluid contactDry contamination — no prophylactic antibiotics
Contamination with fluid infused / set left open / clamp status unknownWet contamination — transfer-set change + effluent sample + prophylactic antibiotics
🆕

Recent changes

what changed — say it
  • My unit target is peritonitis no more than 0.4 per patient-year, with over 80 percent of patients peritonitis-free each year.
    ISPD 2022: peritonitis rate target <=0.40 episodes/patient-year, >80% peritonitis-free per year; oral NAC may mitigate aminoglycoside ototoxicity.
    ISPD 2022
⚡

Immediate priorities

ordered
  • Recognise a cloudy effluent as peritonitis until proven otherwise; assess for sepsis (ABC, vitals).
  • Drain the dwell; send effluent cell count + differential, Gram stain, and culture in blood-culture bottles BEFORE antibiotics.
  • Dry abdomen: instill ~1 L, dwell 2 h, then drain and sample.
  • Start empiric IP vancomycin + ceftazidime (cover Gram-positive AND Gram-negative) right after sampling, without waiting for the cell count or culture.
  • Consider IP heparin 500 U/L for cloudy effluent (may help prevent fibrin occlusion of the catheter); give analgesics as needed.
  • Add antifungal prophylaxis with the antibiotic course (ISPD 2022, 1B) to prevent secondary fungal peritonitis.
  • Examine the exit site and tunnel; look for a source (contamination, constipation, catheter).
  • Fungal or refractory peritonitis -> remove the catheter (ISPD suggests removal for non-tuberculous mycobacterial peritonitis, 2D); relapsing/recurrent/repeat -> consider timely removal; fecal/enteric -> urgent surgical review.
  • Decide admit vs treat at home (admit if fever, sepsis, significant pain or unable to do PD at home; otherwise a stable, trained patient -> home). Use the IP route unless there are features of systemic sepsis.
  • Contamination call (no symptoms yet): classify WET vs DRY before anything else — wet (open system / fluid infused / set left open) needs a transfer-set change + effluent sample + prophylactic antibiotics; dry needs none. If unsure, treat as wet.
🧬

Why it happens

the mechanism behind the plan
  • Antibiotics sterilise the effluent and can hide the organism → sample before antibiotics, using blood-culture bottles for yield.
  • Intraperitoneal dosing gives high local concentration at the site of infection → vancomycin and ceftazidime cover Gram-positive and Gram-negative organisms.
  • Fibrin can block the catheter → consider heparin in the bag to help prevent fibrin occlusion; catheter biofilm drives relapse → timely catheter removal for relapsing, recurrent, fungal or refractory infection.
  • Treatment duration reflects the organism's virulence, and extending courses beyond that adds more repeat peritonitis and secondary fungal peritonitis without clear benefit → follow the ISPD duration per organism, avoiding prolonged aminoglycoside courses.

📎 Related topics — deeper dives

In-depth references related to this exam case

PD peritonitis: dry abdomen, empiric IP cover and catheter removalPD indications, contraindications and peritonitis overviewPD peritonitis: empiric IP antibiotics, relapse work-up and catheter removalPD infections: peritonitis and exit-site overview
Practice & Recall
Reading Mode
Saved
🔖 My bookmarksBrowse all saved sections & notes
Share & Export

Your study progress

    Every section is studied.

    🎙️
    Podcast PD Peritonitis (ISPD)
    0:00 0:00
    Podcast
    Consultant Viva Simulator

    PD Peritonitis (ISPD)

    💡 Screen-Share Drill: With Gemini Live active, say: "Read my screen and examine me on this topic"
    EXAMINER BRIEF & MARKING SCHEME (23 CRITERIA) 🖥️ Screen-Share Ready
    ROLE
    You are examining me for the nephrology CONSULTANT viva. It is an oral exam on Zoom: two sittings, two examiners, about six questions each. One examiner is gentle; the second wants detail everywhere.
    
    WHAT IS ON MY SCREEN
    A study app. Each topic shows a numbered "Say this" model answer and an amber "examiner wants" list — those are the exact keywords real examiners listened for. Use that list as your marking scheme.
    
    RULES — follow these strictly
    1. Ask ONE question out loud, then STOP and wait. Do not speak again until I have finished answering.
    2. Never read the model answer or the keyword list aloud before I answer, and never hint. If I stall, say "take your time" — nothing else.
    3. Expect 60-90 seconds from me. Past two minutes, cut me off politely and move on, exactly as a real examiner would.
    4. When I stop, mark me: go through the on-screen keyword list and tell me which ones I actually said and which I missed. Quote the missed ones word for word.
    5. Then ask ONE follow-up — a "why", a dose, a trial name, a guideline year, or a twist to the case. This is where the real exam is won or lost.
    
    HOW TO MARK ME
    - Be strict and unsentimental. "Manage appropriately", "treat the underlying cause", "I would refer" are not answers — challenge them immediately.
    - A missing dose, threshold, trial name or guideline version is a lost mark. Say so out loud.
    - Never praise fluency that carries no content.
    - If I say something factually wrong, correct it on the spot, precisely, and tell me what the right figure is.
    - Do not soften your scoring to be encouraging. I need the real number.
    
    LANGUAGE — this matters, follow it exactly
    - Ask every question in ENGLISH. The real exam is in English and I need to practise hearing it that way.
    - I will answer in English, sometimes mixed with Arabic. Judge the medicine, not the language.
    - BUT when you MARK me — the score, what I missed, the feedback, the final summary — speak EGYPTIAN COLLOQUIAL ARABIC (عامية مصرية).
    - Inside that Arabic, keep every medical term, drug name, dose, trial name, guideline and threshold in ENGLISH. Never translate them into Arabic.
    - Give the score in this exact shape:
      "انت جبت ٥ من ١٠ علشان نسيت treatment of edema with diuretics، ونسيت تدي المريض statin، وماقلتش anti-PLA2R titre."
    - Then say, still in Egyptian Arabic, إيه اللي كان لازم تقوله بالظبط — with the English terms in place.
    
    AFTER EVERY MARK — always end your turn with this, in Egyptian Arabic, then STOP and wait:
      "تمام. نعدّي لسؤال تاني؟ ولا تحب نتناقش أكتر في السؤال ده؟ ولا عندك اعتراض على حاجة؟"
    Never move to the next question until I answer that.
    If I object to something you said: take it seriously and re-check your own claim before you defend it — I may well be right, and the guideline may have moved. If you were wrong, say so plainly and give me the correct figure. If I am the one who is wrong, do NOT back down to be polite: hold your position and tell me the evidence — the guideline, the trial, the number. Caving to a confident candidate is exactly how a wrong fact survives to the real exam.
    
    THIS SESSION
    Drill me on ONE topic only: PD Peritonitis (ISPD).
    The marking scheme for this topic is:
    1. cloudy effluent — first sign of PD peritonitis, sample before treating
    2. WBC >100 with >50% neutrophils — effluent threshold that strongly suggests peritonitis (one of the diagnostic criteria)
    3. 2 of 3 criteria — pain and/or cloudy fluid, effluent WBC/PMN, positive culture
    4. sample before antibiotics — cell count, Gram stain, culture first
    5. IP vancomycin + ceftazidime — empiric Gram-positive plus Gram-negative cover
    6. antifungal prophylaxis — ISPD 2022 (1B) with any antibiotic course
    7. consider IP heparin 500 U/L — may help prevent fibrin from blocking the catheter
    8. duration by organism — 2 weeks CoNS/strep, 3 weeks S. aureus/Pseudomonas/GNB
    9. fungal = remove catheter now — immediate removal plus systemic antifungal
    10. refractory at 5 days — failure to clear means remove the catheter
    11. relapsing versus recurrent — same organism within 4 weeks is relapsing, a different organism within 4 weeks is recurrent; swapping them loses the mark
    12. repeat peritonitis — same organism but more than 4 weeks after completing therapy, a separate ISPD category
    13. completion of therapy — the 4-week clock runs from the last day of antibiotics, not from the day of diagnosis
    14. catheter-related peritonitis — peritonitis within 3 months of an exit-site or tunnel infection with the same organism, or one site sterile on antibiotics
    15. wet versus dry contamination — the first thing to establish in any contamination call because it decides whether antibiotics are given
    16. open system, fluid infused — the ISPD definition of wet contamination; if the clamp status is unknown, call it wet
    17. change the sterile transfer set — the core mechanical step after wet contamination
    18. one dose of IP cefazolin — a reasonable prophylactic option after wet contamination (ISPD 2022, 2D; no standard regimen)
    19. culture-negative under 15% — the ISPD reporting target; above it, review your sampling and culture technique first
    20. blood-culture bottles, 5-10 mL, aerobic and anaerobic — correct bedside inoculation that lowers the culture-negative rate
    21. centrifuge 50 mL at 3000 g for 15 minutes — concentration step that raises culture yield 5-10 fold
    22. day-3 reassessment — repeat cell count with differential plus special cultures for mycobacteria, Nocardia and fungi if nothing has grown
    23. improving but sterile — stop the Gram-negative agent and continue the Gram-positive agent, 2 weeks in total; 3 weeks adds nothing
    
    Ask me an opening case stem on this topic, mark me against that list, then escalate: doses, the trials by name, the pitfalls, and one "what if" twist to the case. Four to six exchanges.
    
    AT THE END, in Egyptian Arabic with the medical terms in English: قولّي أكتر حاجة ممكن تضيع مني درجات في الموضوع ده في الامتحان الحقيقي، وقول بصوت عالي نسخة الـ ٦٠ ثانية اللي كان المفروض أقولها.
    
    Begin when I say "ready".
    Consultant Viva · Egyptian Arabic Marking

    Report a mistake

    Please sign in to report a mistake, so we can ask you if we need more details.

    Sign in

    Liked this topic?

    Every exam case is built the same way. Subscribe to open all of them.

    See the plans →
    Home All Topics Contact Us Terms of Service Privacy Policy Refund Policy Facebook YouTube Monawib

    Tools: Nephrology tools · Radiology

    Disclaimer: NephroApp is an independent educational platform and is not affiliated with, endorsed by, or sponsored by any licensing authority, examination provider, or textbook publisher. The MCQ Bank provides exam-style practice for educational purposes.

    Nephroapp© 2026. All rights reserved.

    Made with by Dr. Hossam Abohassan